Development of Some Antiplatelet Salts as Drug Active Ingredients and Investigation Biological Activities

dc.contributor.authorUslu, Harun
dc.contributor.authorSatilmis, Basri
dc.contributor.authorUyumlu, Ayse Burcin
dc.contributor.authorSaglik, Begum Nurpelin
dc.contributor.authorLevent, Serkan
dc.contributor.authorOzkay, Yusuf
dc.contributor.authorBenkli, Kadriye
dc.date.accessioned2026-08-12T17:07:33Z
dc.date.issued2023
dc.departmentFırat Üniversitesi
dc.description.abstractIn this study, prasugrel and prasugrel salts: prasugrel + trans-1,2-cyclohexanedicarboxylic acid (1a), prasugrel + maleic acid (2a), prasugrel + citric acid (3a), prasugrel + oxalic acid (4a), and prasugrel + trometamol (5a) were synthesized and investigated for their biological activities.Ex vivo antiplatelet and in vitro cytotoxic activities were experimentally researched. Antiproliferative activity was not observed for prasugrel and prasugrel salts, and it was also determined that there was no cytotoxic effect. Ex vivo experiments were carried out on diabetic and nondiabetic rats. When the study results were examined, 2a and 3a were seen to be effective prasugrel salts for antiplatelet activity.
dc.description.sponsorshipSAN-TEZ Project; Republic of Turkey Ministry of Science Industry and Technology General Directorate of Science and Technology; [0122.STZ.2013 - 1]
dc.description.sponsorshipThis research was funded by SAN-TEZ Project (Project No: 0122.STZ.2013 - 1) with the support of the Republic of Turkey Ministry of Science Industry and Technology General Directorate of Science and Technology, in cooperation with & Yacute;nonu University and Abdi Ibrahim Pharmaceuticals.
dc.identifier.doi10.1007/s11094-024-03032-1
dc.identifier.endpage1270
dc.identifier.issn0091-150X
dc.identifier.issn1573-9031
dc.identifier.issue8
dc.identifier.orcid0000-0003-4281-3301
dc.identifier.orcid0000-0002-6244-0517
dc.identifier.orcid0000-0001-6663-2287
dc.identifier.orcid0000-0001-8827-8557
dc.identifier.orcid0000-0002-2538-5774
dc.identifier.scopus2-s2.0-85181684759
dc.identifier.scopusqualityQ4
dc.identifier.startpage1260
dc.identifier.urihttps://doi.org/10.1007/s11094-024-03032-1
dc.identifier.urihttps://hdl.handle.net/11508/49700
dc.identifier.volume57
dc.identifier.wosWOS:001137703700004
dc.identifier.wosqualityQ4
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.language.isoen
dc.publisherSpringer
dc.relation.ispartofPharmaceutical Chemistry Journal
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.snmzKA_WoS_20260511
dc.subjectPrasugrel
dc.subjectPrasugrel salts
dc.subjectantiplatelet
dc.subjectcytotoxic
dc.subjectdiabetes
dc.titleDevelopment of Some Antiplatelet Salts as Drug Active Ingredients and Investigation Biological Activities
dc.typeArticle

Dosyalar